Cochrane Abstracts
Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral 5‐aminosalicylic Acid for Maintenance of Medically‐induced Remission in Crohn's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438886/all/Electroconvulsive_therapy_for_treatment‐resistant_schizophrenia_New. Accessed 01 December 2023.
Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438886/all/Electroconvulsive_therapy_for_treatment‐resistant_schizophrenia_New. Accessed December 1, 2023.
Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438886/all/Electroconvulsive_therapy_for_treatment‐resistant_schizophrenia_New
Oral 5‐aminosalicylic Acid for Maintenance of Medically‐induced Remission in Crohn's Disease [Internet]. In: Cochrane Abstracts. [cited 2023 December 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438886/all/Electroconvulsive_therapy_for_treatment‐resistant_schizophrenia_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
ID - 438886
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438886/all/Electroconvulsive_therapy_for_treatment‐resistant_schizophrenia_New
DB - Evidence Central
DP - Unbound Medicine
ER -
